These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19659923)

  • 1. Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.
    Nayyar T; Bubser M; Ferguson MC; Neely MD; Shawn Goodwin J; Montine TJ; Deutch AY; Ansah TA
    Eur J Neurosci; 2009 Jul; 30(2):207-16. PubMed ID: 19659923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM; Murphy DL
    J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease.
    Jiménez-Sánchez L; Blesa J; Del Rey NL; Monje MHG; Obeso JA; Cavada C
    Neuropharmacology; 2020 Jun; 170():107806. PubMed ID: 31589886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age- and duration-dependent effects of MPTP on cortical serotonin systems.
    Ansah TA; Ferguson MC; Nayyar T; Deutch AY
    Neurosci Lett; 2011 Oct; 504(2):160-164. PubMed ID: 21964387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
    Andrews AM; Ladenheim B; Epstein CJ; Cadet JL; Murphy DL
    Mol Pharmacol; 1996 Dec; 50(6):1511-9. PubMed ID: 8967972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
    Unger EL; Mazzola-Pomietto P; Murphy DL; Andrews AM
    J Pharmacol Exp Ther; 2002 Nov; 303(2):527-33. PubMed ID: 12388632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
    Andrews AM; Murphy DL
    Eur J Pharmacol; 1993 Dec; 250(2):215-21. PubMed ID: 8112382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.
    Masilamoni GJ; Weinkle A; Papa SM; Smith Y
    Cereb Cortex; 2022 Apr; 32(9):1804-1822. PubMed ID: 34519330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Neurosci Lett; 1990 Jul; 114(3):316-22. PubMed ID: 2402341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.
    Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N
    Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine induces serotonergic axon sprouting in cerebral cortex of newborn rat.
    Blue ME; Molliver ME
    Brain Res; 1987 Apr; 429(2):255-69. PubMed ID: 3105821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
    Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
    J Pharmacol Exp Ther; 2002 Dec; 303(3):952-8. PubMed ID: 12438514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
    Date I; Felten DL; Felten SY
    Brain Res; 1990 Jun; 519(1-2):266-76. PubMed ID: 1975765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
    Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
    Luellen BA; Szapacs ME; Materese CK; Andrews AM
    Neuropharmacology; 2006 Mar; 50(3):297-308. PubMed ID: 16288930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Di Paolo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.